
Superpower launches peptide preorders with blood tests. What does the evidence say?
On October 30, 2026, Superpower announced a peptide program combining clinician assessment, blood testing and follow-up with BPC-157, TB-500 and MOTS-c prescriptions. The company lists BPC-157 and TB-500 at $149 a month and MOTS-c at $199 a month, charges the first month at preorder, and targets shipping in late November; a clinician reviews the prescription request when the company is ready to ship. Superpower says it will issue a full refund if the prescription is declined. The products are not FDA-approved, and FDA has identified major gaps in human safety data for these substances. Monitoring can help manage care, but normal blood tests cannot establish that a treatment works or is safe long term. Before paying, ask about eligibility, cancellation terms and the prescribing pharmacy.



